Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
146.85B
Market cap146.85B
Price-Earnings ratio
19.69
Price-Earnings ratio19.69
Dividend yield
6.70%
Dividend yield6.70%
Average volume
41.11M
Average volume41.11M
High today
$26.18
High today$26.18
Low today
$25.70
Low today$25.70
Open price
$25.83
Open price$25.83
Volume
17.41M
Volume17.41M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$21.97
52 Week low$21.97

Stock Snapshot

The current Pfizer(PFE) stock price is $25.77, with a market capitalization of 146.85B. The stock trades at a price-to-earnings (P/E) ratio of 19.69 and offers a dividend yield of 6.7%.

On 2026-05-11, Pfizer(PFE) stock traded between a low of $25.70 and a high of $26.18. Shares are currently priced at $25.77, which is +0.3% above the low and -1.6% below the high.

The Pfizer(PFE)'s current trading volume is 17.41M, compared to an average daily volume of 41.11M.

In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $21.97.

In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $21.97.

PFE News

24/7 Wall St. 1h
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax? By David Moadel Published May 11, 10:53AM EDT Quick Read Moder...

Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
Nasdaq 2h
PFE November 20th Options Begin Trading

Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the November 20th expiration. One of the key inputs that goes into the price an o...

PFE November 20th Options Begin Trading
24/7 Wall St. 3h
Pfizer vs Eli Lilly: Different Bets on Pharma M&A

The analyst who called NVIDIA in 2010 just named his top 10 stocks and Eli Lilly wasn't one of them. Get them here FREE . For a retirement-focused investor, on...

Pfizer vs Eli Lilly: Different Bets on Pharma M&A

Analyst ratings

50%

of 30 ratings
Buy
40%
Hold
50%
Sell
10%

More PFE News

Simply Wall St 2d
What Pfizer's Earnings Beat, Reaffirmed Guidance and Oncology Wins Mean For Shareholders

In early May 2026, Pfizer reported first-quarter revenue of US$14.45 billion, up from US$13.72 billion a year earlier, while net income eased to US$2.69 billion...

What Pfizer's Earnings Beat, Reaffirmed Guidance and Oncology Wins Mean For Shareholders
Nasdaq 2d
Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?

Key Points Pfizer's stock has lost more than 50% of its value and has a huge 6.5% dividend yield. Long-term dividend investors could get income and growth if...

Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?
TipRanks 2d
Pfizer Juggles Cancer Setbacks and Lyme Vaccine Push

Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Claim 55% Off TipRanks Unlock hedge fund-level data...

TipRanks 3d
Pfizer’s New Phase 1 Cancer Trial Signals Fresh Oncology Push for PFE Investors

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...

TipRanks 3d
Pfizer Terminates Early-Stage Cancer Trial: What It Means for PFE Investors

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...

Simply Wall St 3d
Assessing Pfizer’s Valuation As Shares Hover Near Recent Levels

Advertisement Why Pfizer (PFE) is on investors’ radar today Pfizer (PFE) is back in focus after recent trading left the stock around $26.48. This has prompted...

Assessing Pfizer’s Valuation As Shares Hover Near Recent Levels
TipRanks 4d
Pfizer’s Next Lyme Shot: What a Fifth-Dose VLA15 Trial Signals for PFE Investors

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.